Advances in Cancer Immunotherapy™

Specifically designed for clinical oncologists, registered nurses, nurse practitioners, and the entire medical team involved in treating cancer patients with immunotherapy, these introductory, CME- and CNE-certified programs will provide an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field.

Presented by leading authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of 1) the underlying principles of tumor immunology and immunotherapy, 2) the clinical indications for cancer immunotherapy and appropriate selection of patients, 3) patient management, and 4) the therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes.

Attendees can also take advantage of the opportunity for professional networking that will promote collaboration and scientific exchange with experts, clinical oncologists and other health care providers from the surrounding community.



+ show speakers and program
Organizers:

Omid Hamid, MD – The Angeles Clinic and Research Institute
Stephen L. Shiao, MD, PhD – Cedars-Sinai Medical Center

Topics:
- Immunology 101 for the Non-Immunologist
- Basic Principles of Tumor Immunotherapy
- Basic Mechanisms of Tumor Immune Suppression
- Cytokines: Interferons, Interleukins and Beyond
- Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies
- Active Immunization Approaches
- Current Status of Chimeric and Adoptive T Cell Therapy
- Is There a Role for Radiation Therapy and Immunotherapy?
- Immune-Related Adverse Events
- Immunotherapy for the Treatment of:
- Melanoma
- GU Malignancies
- Non-Small Cell Lung Carcinoma
- Hematologic Malignancies
- Brain Metastases

19 Jun - 19 Jun 2015
Los Angeles
United States of America
meeting website